Cargando…

Risk Factors for Mortality after COVID-19 in Patients with Preexisting Interstitial Lung Disease

Detalles Bibliográficos
Autores principales: Gallay, Laure, Uzunhan, Yurdagül, Borie, Raphael, Lazor, Romain, Rigaud, Pierre, Marchand-Adam, Sylvain, Hirschi, Sandrine, Israel-Biet, Dominique, Valentin, Victor
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Thoracic Society 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7874431/
https://www.ncbi.nlm.nih.gov/pubmed/33252997
http://dx.doi.org/10.1164/rccm.202007-2638LE
_version_ 1783649587735560192
author Gallay, Laure
Uzunhan, Yurdagül
Borie, Raphael
Lazor, Romain
Rigaud, Pierre
Marchand-Adam, Sylvain
Hirschi, Sandrine
Israel-Biet, Dominique
Valentin, Victor
author_facet Gallay, Laure
Uzunhan, Yurdagül
Borie, Raphael
Lazor, Romain
Rigaud, Pierre
Marchand-Adam, Sylvain
Hirschi, Sandrine
Israel-Biet, Dominique
Valentin, Victor
author_sort Gallay, Laure
collection PubMed
description
format Online
Article
Text
id pubmed-7874431
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher American Thoracic Society
record_format MEDLINE/PubMed
spelling pubmed-78744312021-02-11 Risk Factors for Mortality after COVID-19 in Patients with Preexisting Interstitial Lung Disease Gallay, Laure Uzunhan, Yurdagül Borie, Raphael Lazor, Romain Rigaud, Pierre Marchand-Adam, Sylvain Hirschi, Sandrine Israel-Biet, Dominique Valentin, Victor Am J Respir Crit Care Med Correspondence American Thoracic Society 2021-01-15 2021-01-15 /pmc/articles/PMC7874431/ /pubmed/33252997 http://dx.doi.org/10.1164/rccm.202007-2638LE Text en Copyright © 2021 by the American Thoracic Society https://creativecommons.org/licenses/by-nc-nd/4.0/This article is open access and distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives License 4.0 (http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) ). For commercial usage and reprints, please contact Diane Gern (dgern@thoracic.org).
spellingShingle Correspondence
Gallay, Laure
Uzunhan, Yurdagül
Borie, Raphael
Lazor, Romain
Rigaud, Pierre
Marchand-Adam, Sylvain
Hirschi, Sandrine
Israel-Biet, Dominique
Valentin, Victor
Risk Factors for Mortality after COVID-19 in Patients with Preexisting Interstitial Lung Disease
title Risk Factors for Mortality after COVID-19 in Patients with Preexisting Interstitial Lung Disease
title_full Risk Factors for Mortality after COVID-19 in Patients with Preexisting Interstitial Lung Disease
title_fullStr Risk Factors for Mortality after COVID-19 in Patients with Preexisting Interstitial Lung Disease
title_full_unstemmed Risk Factors for Mortality after COVID-19 in Patients with Preexisting Interstitial Lung Disease
title_short Risk Factors for Mortality after COVID-19 in Patients with Preexisting Interstitial Lung Disease
title_sort risk factors for mortality after covid-19 in patients with preexisting interstitial lung disease
topic Correspondence
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7874431/
https://www.ncbi.nlm.nih.gov/pubmed/33252997
http://dx.doi.org/10.1164/rccm.202007-2638LE
work_keys_str_mv AT gallaylaure riskfactorsformortalityaftercovid19inpatientswithpreexistinginterstitiallungdisease
AT uzunhanyurdagul riskfactorsformortalityaftercovid19inpatientswithpreexistinginterstitiallungdisease
AT borieraphael riskfactorsformortalityaftercovid19inpatientswithpreexistinginterstitiallungdisease
AT lazorromain riskfactorsformortalityaftercovid19inpatientswithpreexistinginterstitiallungdisease
AT rigaudpierre riskfactorsformortalityaftercovid19inpatientswithpreexistinginterstitiallungdisease
AT marchandadamsylvain riskfactorsformortalityaftercovid19inpatientswithpreexistinginterstitiallungdisease
AT hirschisandrine riskfactorsformortalityaftercovid19inpatientswithpreexistinginterstitiallungdisease
AT israelbietdominique riskfactorsformortalityaftercovid19inpatientswithpreexistinginterstitiallungdisease
AT valentinvictor riskfactorsformortalityaftercovid19inpatientswithpreexistinginterstitiallungdisease